Evidence map›Paper›PMID 35163596›Full record

ArticleInternational journal of molecular sciences2022

Enhanced Bacteremia in Dextran Sulfate-Induced Colitis in Splenectomy Mice Correlates with Gut Dysbiosis and LPS Tolerance.

Arthid Thim-Uam, Jiradej Makjaroen, Jiraphorn Issara-Amphorn, Wilasinee Saisorn, Dhammika Leshan Wannigama, Wiwat Chancharoenthana, Asada Leelahavanichkul

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Skin and gut microbiome in atopic dermatitis: Mechanisms and therapeutic opportunities.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025
    Review
  6. Article
  7. Splenectomy and risk of hepatocellular carcinoma.World journal of hepatology · 2025
    Review
  8. ProbioticAntioxidants (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Less Severe Polymicrobial Sepsis in ConditionalInternational journal of molecular sciences · 2023
    Article
  15. Less Severe Lipopolysaccharide-Induced Inflammation in ConditionalInternational journal of molecular sciences · 2023
    Article
  16. Article
  17. Article
  18. The Regulatory Roles ofInternational journal of molecular sciences · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Arthid Thim-UamDivision of Biochemistry, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
Jiradej MakjaroenCenter of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University, Bangkok 10400, Thailand.ORCID 0000-0001-6025-0106
Jiraphorn Issara-AmphornDepartment of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10400, Thailand.
Wilasinee SaisornDepartment of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10400, Thailand.ORCID 0000-0002-0074-0389
Dhammika Leshan WannigamaDepartment of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10400, Thailand.ORCID 0000-0001-6316-1221
Wiwat ChancharoenthanaTropical Nephrology Research Unit, Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0002-2965-146X
Asada LeelahavanichkulDepartment of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10400, Thailand.
Chulalongkorn University · THMahidol University · TH

Funding

Chulalongkorn university through Fundamental Fund 2565 and National Research Council of Thailand NRCT5-RGJ63001National Research Council of Thailand with NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation NRCT-N41A640076the Thailand science research and innovation fund and the University of Phayao FF64-RIB008the Thailand science research and innovation fund and the University of Phayao FF64-UoE020TRF, International Network for Lupus Research, Thailand IRN59W0004
6 · The paper itself

Abstract

Because both endotoxemia and gut dysbiosis post-splenectomy might be associated with systemic infection, the susceptibility against infection was tested by dextran sulfate solution (DSS)-induced colitis and lipopolysaccharide (LPS) injection models in splenectomy mice with macrophage experiments. Here, splenectomy induced a gut barrier defect (FITC-dextran assay, endotoxemia, bacteria in mesenteric lymph nodes, and the loss of enterocyte tight junction) and gut dysbiosis (increased Proteobacteria by fecal microbiome analysis) without systemic inflammation (serum IL-6). In parallel, DSS induced more severe mucositis in splenectomy mice than sham-DSS mice, as indicated by mortality, stool consistency, gut barrier defect, serum cytokines, and blood bacterial burdens. The presence of green fluorescent-producing (GFP)

Indexed as

SplenectomyAnimalsBacteremiaColitisDextran SulfateDysbiosisImmune ToleranceLipopolysaccharidesMaleMiceDextran SulfateLipopolysaccharidesdysbiosisendotoxemiagut barrier defectsplenectomy

Identifiers

PMID35163596
PMCPMC8836212
OpenAlexW4210383176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.